PTCy Offers New Hope for Mismatched Stem Cell Transplants in Leukemia, MDS
Jeff Auletta, MD, discussed how PTCy-based graft-vs-host disease prophylaxis offers a promising approach for expanding access to successful cell transplantation regardless of donor match or patient ethnicity.